Study S001948

The Microvascular Function of GLP-1 and Its Analogues in Humans, in Vivo: the Role of DPP-IV Inhibition

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01677104
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: TRIPLE
Status: COMPLETED
Enrollment: 63
Start: 2012-08
Primary completion: 2014-07
Lead sponsor: Katarina Kos
Conditions: Type 2 Diabetes; Obesity
Interventions: DRUG:GLP-1; DRUG:Placebo
Results posted: FALSE
Secondary identifiers: OTHER:1204620

Registered primary outcomes

skin blood flow [3 hours]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0016142	Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes. Aung MM, Diabetologia	2019	Randomized trial	PMID 31203378 DOI	cites ClinicalTrials.gov:NCT01677104; registry reference DERIVED:31203378